본문 바로가기

Journals

  • Home
  • Cyber Information Center
  • Journals
Journals
Journal Corresponding Author Writer,Title,Journal,Publication;Year;Page:Volume(Impact Factor)
First Author
Targeting S1PR1 in Thyroid Cancer: Functional Characterization and Proteasome-Mediated Suppression by Quercetin Ryu Jun sun
(Department of Otorhinolaryngology)


()
. Targeting S1PR1 in Thyroid Cancer: Functional Characterization and Proteasome-Mediated Suppression by Quercetin. MOLECULAR CARCINOGENESIS. 2025-12-03; 2025; :~. IF 3.2 (2024)
Evaluation of false positive and false negative errors in targeted next generation sequencing Hong Kyeong Man
(Cancer Molecular Biology Branch)

Youngbeen Moon
(Bioinformatics Analysis Team)
. Evaluation of false positive and false negative errors in targeted next generation sequencing. GENOME BIOLOGY. 2025-12-01; 2025; 26(1):409~. IF 9.4 (2024)
K-LARS trial: protocol for a multicentre randomised controlled trial evaluating a knowledge-enhanced digital intervention to prevent low anterior resection syndrome in Korea Sohn Dae Kyung
(Medical Engineering Branch)


()
. K-LARS trial: protocol for a multicentre randomised controlled trial evaluating a knowledge-enhanced digital intervention to prevent low anterior resection syndrome in Korea. BMJ OPEN. 2025-11-29; 2025; 15(11):e107819~. IF 2.3 (2024)
Development of a real-time tongue motion monitoring system for managing swallowing-induced motion in neck cancer radiation therapy Shin Dong ho
(Department of Radiation oncology)


()
. Development of a real-time tongue motion monitoring system for managing swallowing-induced motion in neck cancer radiation therapy. MEDICAL PHYSICS. 2025-11-27; 2025; 52(12):e70137~. IF 3.2 (2024)
Lorlatinib in Tyrosine Kinase Inhibitor-Naive Advanced ROS1-Positive Non-Small Cell Lung Cancer: A Phase 2 Nonrandomized Clinical Trial Han Ji-Youn
(Anticancer Resistance Branch )

Ahn Beung Chul
(Targeted Therapy Branch)
. Lorlatinib in Tyrosine Kinase Inhibitor-Naive Advanced ROS1-Positive Non-Small Cell Lung Cancer: A Phase 2 Nonrandomized Clinical Trial. JAMA ONCOLOGY. 2025-11-26; 2025; 12(1):84~89. IF 20.1 (2024)
Comparable long-term survival and biliary outcomes in ABO-incompatible and compatible living donor liver transplantation Kim Seoung Hoon
(Organ Transplantation Center)

Kim Seoung Hoon
(Organ Transplantation Center)
. Comparable long-term survival and biliary outcomes in ABO-incompatible and compatible living donor liver transplantation. INTERNATIONAL JOURNAL OF SURGERY. 2025-11-25; 2025; :~. IF 10.3 (2024)
Pattern of first recurrence in advanced epithelial ovarian, fallopian tube and peritoneal cancers treated with cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy LIM MYONG CHEOL
(Department of Obstetrics and Gynecology)

Kim Ji Hyun
(Department of Obstetrics and Gynecology)
. Pattern of first recurrence in advanced epithelial ovarian, fallopian tube and peritoneal cancers treated with cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy. JOURNAL OF GYNECOLOGIC ONCOLOGY. 2025-11-25; 2025; 37:e52~. IF 3.7 (2024)
Comparative feasibility of reasoning and non-reasoning large language models for gynecologic cancer emergency care LIM MYONG CHEOL
(Department of Obstetrics and Gynecology)

Kim Jun Hwan
(Department of Obstetrics and Gynecology)
. Comparative feasibility of reasoning and non-reasoning large language models for gynecologic cancer emergency care. BMC HEALTH SERVICES RESEARCH. 2025-11-24; 2025; 25:1513~. IF 3 (2024)
Information Landscape on Cervical Cancer: An Analysis of News and Online Platform Data in the Republic of Korea Jun Jae Kwan
(Division of Cancer Screening and Early Detection)

Hye-Sun Lee
(Division of Cancer Screening and Early Detection)
. Information Landscape on Cervical Cancer: An Analysis of News and Online Platform Data in the Republic of Korea. HEALTH COMMUNICATION. 2025-11-24; 2025; :1~19. IF 2.7 (2024)
Minimally invasive steam-assisted drug delivery with ICG fluorescence guidance for primary malignant bone tumors and evaluation of clinical applicability Kang, Hyun Guy
(Medical Engineering Branch)


()
. Minimally invasive steam-assisted drug delivery with ICG fluorescence guidance for primary malignant bone tumors and evaluation of clinical applicability. PLOS ONE. 2025-11-21; 2025; 20(11):e0335740~. IF 2.6 (2024)
First page Prev paging 1 2 3 4 5 6 7 8 9 10 next paging last page